Skip to main content Skip to main navigation menu Skip to site footer

Matrix Metalloproteinase as Predictors of Local Recurrence in Early-Stage Breast Cancer After Mastectomy and Chemotherapy A Cross-Sectional Study in Single Centre


Introduction: The prognosis for early-stage breast cancer is generally favourable. However, in cases when a recurrence manifests after therapy, the prognosis becomes significantly poor. To determine early breast cancer recurrence risk, a marker is needed. Currently, previous tumour markers are used to predict general breast cancer, lacking specificity in the context of early breast cancer. Matrix Metalloproteinase1 (MMP1) is already acquainted with the local recurrence process of invasive ductal carcinoma (IDC). MMP1 expression may better predict early recurrence in early-stage IDC than other approaches. This research examined the potential predictive value of MMP1 expression in early-stage IDC for early local recurrence and its correlation with clinicopathological factors.

Methods: This study was a cross-sectional analysis of a single center's medical records. The sample size was 25 subjects for the group without recurrence and 25 subjects with recurrence. Mastectomy and chemotherapy were performed from January 2014 through December 2019. Using immunohistochemistry, paraffin blocks of surgical specimens were examined for MMP1. The data processing was done utilising the trial version of IBM SPSS 25. and Openepi 3.0 programs and analysed using Bivariate, which is performed using the Chi-square test or Fisher's exact test.

Result: The statistic test showed a significant difference (p < 0.000) in the average expression of MMP1 for non-recurrence cases (3,95±5,36) compared to recurrence cases (14,95±5,36). We also found a statistically significant correlation between recurrence and high expression of MMP1 (odd ratio [OR]= 60.38, 95% confidence interval [CI]=10.01-364.3, p<0.001). Clinicopathological variables and MMP1 expression did not have a significant correlation.

Conclusions: In early-stage IDC, MMP1 expression had the potential to predict and could be an independent prognostic factor for early recurrence.


  1. Kemenkes. Panduan Penatalaksanaan Kanker Payudara. Kementerian Kesehatan Republik Indonesia. 2015;1–50. Available from:
  2. Kennecke H, Yerushalmi R, Woods R, Cheang MCU, Voduc D, Speers CH, et al. Metastatic behavior of breast cancer subtypes. Journal of Clinical Oncology. 2010;28(20):3271–7.
  3. Rivera-Franco MM, Leon-Rodriguez E. Delays in breast cancer detection and treatment in developing countries. Breast Cancer (Auckl). 2018;12.
  4. Benish M, Ben-Eliyahu S. Surgery as a double-edged sword: A clinically feasible approach to overcome the metastasis-promoting effects of surgery by blunting stress and prostaglandin responses. Cancers (Basel). 2010;2(4):1929–51.
  5. Al-Hilli Z, Grobmyer SR. Management Strategies for Locally Recurrent Breast Cancer: Redo-Lumpectomy, Redo-Sentinel Node Biopsy, Redo-Radiation. Ann Surg Oncol. 2019;26(10):3018–24. Available from:
  6. Cianfrocca M, Gradishar WJ. Controversies in the Therapy of Early Stage Breast Cancer. Oncologist. 2005;10(10):766–79.
  7. Hassan MSU, Ansari J, Spooner D, Hussain SA. Chemotherapy for breast cancer (review). Vol. 24, Oncology Reports. Spandidos Publications; 2010. p. 1121–31.
  8. Wang QM, Lv LI, Tang Y, Zhang LI, Wang LF. MMP-1 is overexpressed in triple-negative breast cancer tissues and the knockdown of MMP-1 expression inhibits tumor cell malignant behaviors in vitro. Oncol Lett. 2019;17(2):1732–40.
  9. Figueira RCS, Gomes LR, Neto JS, Silva FC, Silva IDCG, Sogayar MC. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer. 2009;9:1–11.
  10. Cui Q, Wang B, Li K, Sun H, Hai T, Zhang Y, et al. Upregulating MMP 1 in carcinoma associated fibroblasts reduces the efficacy of taxotere on breast cancer synergized by collagen IV. Oncol Lett. 2018;16(3):3537–44.
  11. Jenkins DG, Quintana-Ascencio PF. A solution to minimum sample size for regressions. PLoS One. 2020;15(2):1–15.
  12. Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA. Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease. J Am Coll Surg. 2009;208(3):341–7.
  13. Tonellotto F, Bergmann A, de Souza Abrahão K, de Aguiar SS, Bello MA, Thuler LCS. Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer. Eur J Breast Health. 2019;15(2):76–84.
  14. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer [Internet]. Available from:
  15. Demicheli R, Bonadonna G, Hrushesky WJM, Retsky MW, Valagussa P. Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour. Breast Cancer Research. 2004;6(6).
  16. Vicini FA, Kestin L, Huang R, Martinez A. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer. 2003;97(4):910–9. Available from:
  17. Shiraishi A, Tachi K, Essid N, Tsuboi I, Nagano M, Kato T, et al. Hypoxia promotes the phenotypic change of aldehyde dehydrogenase activity of breast cancer stem cells. Cancer Sci. 2017;108(3):362–72.
  18. Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, et al. The role of cellular reactive oxygen species in cancer chemotherapy. Journal of Experimental and Clinical Cancer Research. 2018;37(1):1–10.
  19. Maquoi E, Assent D, Detilleux J, Pequeux C, Foidart JM, Noël A. MT1-MMP protects breast carcinoma cells against type i collagen-induced apoptosis. Oncogene. 2012;31(4):480–93.
  20. Boström P, Söderström M, Vahlberg T, Söderström KO, Roberts PJ, Carpén O, et al. MMP-1 expression has an independent prognostic value in breast cancer. BMC Cancer. 2011;11.
  21. Shen CJ, Kuo YL, Chen CC, Chen MJ, Cheng YM. MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PLoS One. 2017;12(3).
  22. Ojha U, Goel S. A study on prediction of breast cancer recurrence using data mining techniques. In: 2017 7th International Conference on Cloud Computing, Data Science & Engineering - Confluence. 2017. p. 527–30.
  23. Zain ZM, Alshenaifi M, Aljaloud A, Albednah T, Alghanim R, Alqifari A, et al. Predicting breast cancer recurrence using principal component analysis as feature extraction: An unbiased comparative analysis. International Journal of Advances in Intelligent Informatics. 2020;6(3):313–27.

How to Cite

Andrianto, A., Sudiana, I. K. ., & Suprabawati, D. G. . (2023). Matrix Metalloproteinase as Predictors of Local Recurrence in Early-Stage Breast Cancer After Mastectomy and Chemotherapy A Cross-Sectional Study in Single Centre. Bali Medical Journal, 13(1), 337–341.




Search Panel

Andreas Andrianto
Google Scholar
BMJ Journal

I Ketut Sudiana
Google Scholar
BMJ Journal

Desak G.A Suprabawati
Google Scholar
BMJ Journal